Skip to Main Content

Paper Details

Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies.
Expert Rev Proteomics
3
2022
BRAF, Cancer, I, PARP, breast cancer, cancer, patient, patients, tumor
Author NameAffiliation
Gordon B MillsKnight Cancer Institute, Oregon Health & Science University
Gordon B MillsKnight Cancer Institute, Oregon Health & Science University
  • 1 - 2

Datasets

Release 1.2